adrenal incidentaloma adrenocortical carcinoma urinary steroid profiling
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - adrenal mass > 1 cm in diameter incidentally discovered during CT-scanning, performed for reasons other than an evaluation for adrenal disease - age 18 years or older
Exclusion criteria
Exclusion criteria: - extra-adrenal malignancy (i.e. active or past medical history of malignancy, except for basal cell carcinoma) - radiologic diagnosis of simple cyst or bilateral adrenal masses - allergy to radiocontrast - renal insufficiency (i.e. eGFR <30 /min/1.73m2) - pregnancy - inability to understand written Dutch
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome parameter is the difference in cost-effectiveness of the current management strategy based on repeat CT-scanning to detect adrenocortical carcinoma among patients with an adrenal incidentaloma compared with a strategy using a single baseline urinary steroid profiling. | — |
Secondary
| Measure | Time frame |
|---|---|
| • frequency of adrenocortical carcinoma among patients with an adrenal incidentaloma at baseline or during follow-up. • determination of the percentage of adrenal incidentaloma that fulfils the criteria of a malignant CT-phenotype at baseline or during follow-up. • determination of the pathologic diagnosis in patients who underwent adrenalectomy. • QoL in patients with an adrenal incidentaloma at baseline and during follow-up. • frequency distribution between hormonal hypersecreting and non-functional adrenal incidentaloma. • conversion rate of a non-functioning adrenal incidentaloma towards a hypersecreting adrenal incidentaloma during follow-up. • costs of diagnostic procedures and surgical interventions. | — |
Contacts
Department of Endocrinology University Medical Center Groningen